The GLP Compliance Program requires the FDA investigator to select an ongoing study in order to inspect current laboratory operations what criteria are used to select the study? 941 viewsOctober 10, 2022DrugsPharmaceutical 0 Sam Smith11.38K December 29, 2020 0 Comments 1 Answer ActiveVotedNewestOldest 0 Blogolu28.38K Posted December 29, 2020 0 Comments The studies are selected in accord with agency priorities, i.e. the longest-term study on the most significant product. You are viewing 1 out of 1 answers, click here to view all answers. Register or Login